Search All News
The third authorized vaccine provides protection, particularly against severe illness and death, with just one shot, says Columbia's Jason Zucker, MD.
Jessica Justman, MD, an infectious disease specialist and epidemiologist at Columbia, says vaccinated people still need to take some precautions for now.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.
- March 3, 2021
A 15-minute COVID-19 test that can be used at home to identify infectious people is under development in David Ho’s laboratory and has received support from the NYC Economic Development Corporation.
- February 26, 2021
People who took statins to lower cholesterol were about 50% less likely to die if hospitalized for COVID-19, a retrospective study by Columbia University and NewYork-Presbyterian physicians has found.
- February 25, 2021
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.
- February 15, 2021
Columbia faculty and staff speak about their experiences while volunteering at the Armory vaccination site.
- February 12, 2021
Years before COVID-19, Columbia began laying the groundwork for this month’s symposium on vaccines and pandemic preparedness.
- February 11, 2021
New videos from Hip Hop Public Health, a community organization founded by a Columbia neurologist, are using the power of music to help increase COVID-19 vaccine coverage in communities of color.
- February 5, 2021
Pregnant women face greater risks to their health from COVID-19 than the general population and should be offered a vaccine if eligible, say experts at Columbia and NewYork-Presbyterian.
- February 5, 2021
Cancer patients on active treatment are 35% less likely to develop COVID-19 than patients not receiving treatment, though those who did test positive for SARS-CoV-2 experienced higher death rates.